Metered dose inhalers
Executive Summary
FDA's Generic Drugs and Pulmonary-Allergy Drugs Advisory Committees will discuss results of agency contracted pilot studies of albuterol metered dose inhalers Sept. 14. On Sept. 15, committees will "discuss issues related to current policy concerning the documentation of bioequivalence for solution/device combinations." Meeting will take place at Potomac Inn, Rockville, Md. beginning at 8 a.m. both days.